How is the Metabolic Syndrome Related to the Dyslipidemia?
作者信息
Blaton Victor
机构信息
KU-Leuven and Department Clinical Chemistry, Az St Jan Av, Brugge, Belgium.
出版信息
EJIFCC. 2007 Feb 26;18(1):15-22. eCollection 2007 Feb.
Abstract
摘要
相似文献
1
How is the Metabolic Syndrome Related to the Dyslipidemia?
EJIFCC. 2007 Feb 26;18(1):15-22. eCollection 2007 Feb.
2
Dyslipidemia in the metabolic syndrome: clinical implications and management.
Minerva Cardioangiol. 2006 Apr;54(2):215-27.
3
The metabolic basis of atherogenic dyslipidemia.
Clin Cornerstone. 2005;7(2-3):27-35. doi: 10.1016/s1098-3597(05)80065-1.
4
Management of dyslipidemia in patients with metabolic syndrome.
J Am Pharm Assoc (2003). 2004 Jul-Aug;44(4):478-88; quiz 489-90. doi: 10.1331/1544345041475643.
5
Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
Am J Cardiovasc Drugs. 2007;7(1):39-58. doi: 10.2165/00129784-200707010-00004.
6
Serum metabolomics model and its metabolic characteristics in patients with different syndromes of dyslipidemia based on nuclear magnetic resonance.
J Pharm Biomed Anal. 2019 Apr 15;167:100-113. doi: 10.1016/j.jpba.2018.12.042. Epub 2019 Feb 4.
7
Management of dyslipidemia in the metabolic syndrome.
Cardiovasc Hematol Disord Drug Targets. 2007 Jun;7(2):99-108. doi: 10.2174/187152907780830860.
8
Prevalence of dyslipidemia and metabolic syndrome risk factor in overweight and obese children.
Pediatr Endocrinol Rev. 2014 Dec;12(2):213-23.
9
Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.
J Am Coll Surg. 2008 Dec;207(6):928-34. doi: 10.1016/j.jamcollsurg.2008.08.022. Epub 2008 Oct 10.
10
Evaluation of alterations in serum immunoglobulin concentrations in components of metabolic syndrome, obesity, diabetes, and dyslipidemia.
BMC Cardiovasc Disord. 2019 Dec 30;19(1):319. doi: 10.1186/s12872-019-01296-0.
引用本文的文献
1
Novel biomarkers of the Framingham risk score in patients with depression: A cross-sectional study.
World J Psychiatry. 2025 Aug 19;15(8):106303. doi: 10.5498/wjp.v15.i8.106303.
2
Blood-based biomarkers in centenarians and non-centenarians: a matched, population-based retrospective cohort study using primary care records in Catalonia, Spain.
Biogerontology. 2025 May 26;26(3):115. doi: 10.1007/s10522-025-10258-3.
3
Modifying Alzheimer's disease pathophysiology with photobiomodulation: model, evidence, and future with EEG-guided intervention.
Front Neurol. 2024 Aug 23;15:1407785. doi: 10.3389/fneur.2024.1407785. eCollection 2024.
4
Assessment of leukocyte and systemic inflammation index ratios in dyslipidemia patients with dry eye disease: a retrospective case‒control study.
Lipids Health Dis. 2024 Jun 11;23(1):179. doi: 10.1186/s12944-024-02176-z.
5
The connection between hypertension and diabetes and their role in heart and kidney disease development.
J Res Med Sci. 2024 Apr 29;29:22. doi: 10.4103/jrms.jrms_470_23. eCollection 2024.
6
Overnutrition and Lipotoxicity: Impaired Efferocytosis and Chronic Inflammation as Precursors to Multifaceted Disease Pathogenesis.
Biology (Basel). 2024 Apr 6;13(4):241. doi: 10.3390/biology13040241.
7
Helicobacter pylori components increase the severity of metabolic syndrome and its hepatic manifestations induced by a high fat diet.
Sci Rep. 2024 Mar 8;14(1):5764. doi: 10.1038/s41598-024-56308-7.
8
Association of adiponectin gene expression with atrial fibrillation in a Pakistani populace.
Sci Rep. 2023 Dec 18;13(1):22589. doi: 10.1038/s41598-023-46388-2.
9
Exploring the Potential Performance of Fibroscan for Predicting and Evaluating Metabolic Syndrome using a Feature Selected Strategy of Machine Learning.
Metabolites. 2023 Jul 5;13(7):822. doi: 10.3390/metabo13070822.
10
Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome.
Diagnostics (Basel). 2023 Jul 12;13(14):2348. doi: 10.3390/diagnostics13142348.
本文引用的文献
1
Clinical review 163: Cardiovascular endocrinology: Low-density lipoprotein size and cardiovascular disease: a reappraisal.
J Clin Endocrinol Metab. 2003 Oct;88(10):4525-32. doi: 10.1210/jc.2003-030636.
2
3
Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study.
Arch Intern Med. 2001;161(22):2685-92. doi: 10.1001/archinte.161.22.2685.
4
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.
N Engl J Med. 1999 Aug 5;341(6):410-8. doi: 10.1056/NEJM199908053410604.
5
Banting lecture 1988. Role of insulin resistance in human disease.
Diabetes. 1988 Dec;37(12):1595-607. doi: 10.2337/diab.37.12.1595.
Zotero 插件